Enduro
Biotech startup improving large-scale fermentations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €12.0m | Series A | |
| Total Funding | 000k | ||
| DKK | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Developer of a genetic plugin technology designed to improve large-scale fermentations. The company's technology is free of antibiotic resistance genes, provides high yield at scale by enriching spontaneous high producers in the fermentation population, and eases the production of complex or cellular inhibit products when strain instability is overcome, enabling companies to maximize the performance of all cells cultivated from production strains and increase the competitiveness of current and future green bioproduction.
Keywords: Pharmaceuticals and Biotechnology, Bioproduction Facility, Bioproduction Technology, Biotechnology Research, Genetic Fermentation, Genetic Lines, Genetic Plug-In, Production Strain.